SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095082
Filing Date
2024-08-12
Accepted
2024-08-12 08:32:18
Documents
98
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsha-20240630.htm   iXBRL 10-Q 2028956
2 EX-4.1 tsha-ex4_1.htm EX-4.1 41033
3 EX-31.1 tsha-ex31_1.htm EX-31.1 16125
4 EX-31.2 tsha-ex31_2.htm EX-31.2 16161
5 EX-32.1 tsha-ex32_1.htm EX-32.1 9033
6 EX-32.2 tsha-ex32_2.htm EX-32.2 9069
7 GRAPHIC img39572056_0.jpg GRAPHIC 49073
8 GRAPHIC img39572056_1.jpg GRAPHIC 116861
9 GRAPHIC img39572056_2.jpg GRAPHIC 70437
10 GRAPHIC img39572056_3.jpg GRAPHIC 99208
11 GRAPHIC img39572056_4.jpg GRAPHIC 82564
12 GRAPHIC img39572056_5.jpg GRAPHIC 84422
13 GRAPHIC img39572056_6.jpg GRAPHIC 88441
14 GRAPHIC img39572056_7.jpg GRAPHIC 69435
15 GRAPHIC img39572056_8.jpg GRAPHIC 35460
16 GRAPHIC img39572056_9.jpg GRAPHIC 90564
17 GRAPHIC img39572056_10.jpg GRAPHIC 88398
18 GRAPHIC img39572056_11.jpg GRAPHIC 51097
19 GRAPHIC img39572056_12.jpg GRAPHIC 79759
20 GRAPHIC img39572056_13.jpg GRAPHIC 81752
  Complete submission text file 0000950170-24-095082.txt   12210992

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsha-20240630.xsd EX-101.SCH 1689599
100 EXTRACTED XBRL INSTANCE DOCUMENT tsha-20240630_htm.xml XML 1667273
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39536 | Film No.: 241195005
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)